These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18082664)

  • 1. Effects on serum hormone levels of low-dose estrogen in place of placebo during the hormone-free interval of an oral contraceptive.
    Reape KZ; DiLiberti CE; Hendy CH; Volpe EJ
    Contraception; 2008 Jan; 77(1):34-9. PubMed ID: 18082664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Greater inhibition of the pituitary--ovarian axis in oral contraceptive regimens with a shortened hormone-free interval.
    Willis SA; Kuehl TJ; Spiekerman AM; Sulak PJ
    Contraception; 2006 Aug; 74(2):100-3. PubMed ID: 16860046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary-ovarian hormone levels and symptoms in oral contraceptive users: comparison of a 21/7-day and extended regimen.
    Kuehl TJ; Speikermann AM; Willis SA; Coffee A; Sulak PJ
    J Reprod Med; 2008 Apr; 53(4):266-70. PubMed ID: 18472649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of hormonal suppression with two contraceptive regimens using ethinyl estradiol and desogestrel.
    Gassen DT; Herter LD; Chagas JK; Schmid H
    Arch Gynecol Obstet; 2013 Feb; 287(2):289-94. PubMed ID: 22976131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproductive ageing and ovarian function: is the early follicular phase FSH rise necessary to maintain adequate secretory function in older ovulatory women?
    Hansen KR; Thyer AC; Sluss PM; Bremner WJ; Soules MR; Klein NA
    Hum Reprod; 2005 Jan; 20(1):89-95. PubMed ID: 15550499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval.
    Sulak P; Willis S; Kuehl T; Coffee A; Clark J
    Headache; 2007 Jan; 47(1):27-37. PubMed ID: 17355491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study.
    Duijkers IJ; Klipping C; Verhoeven CH; Dieben TO
    Hum Reprod; 2004 Nov; 19(11):2668-73. PubMed ID: 15333593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced sensitivity to steroid-negative feedback during breast-feeding: low-dose estradiol (transdermal estradiol supplementation) suppresses gonadotropins and ovarian activity assessed by inhibin B.
    Perheentupa A; Critchley HO; Illingworth PJ; McNeilly AS
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4280-6. PubMed ID: 11095468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive.
    Kaunitz AM; Portman DJ; Hait H; Reape KZ
    Contraception; 2009 May; 79(5):350-5. PubMed ID: 19341846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
    Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age.
    Riggs RM; Duran EH; Baker MW; Kimble TD; Hobeika E; Yin L; Matos-Bodden L; Leader B; Stadtmauer L
    Am J Obstet Gynecol; 2008 Aug; 199(2):202.e1-8. PubMed ID: 18674663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibin-producing ovarian granulosa cell tumor as a cause of secondary amenorrhea: case report and review of the literature.
    Kurihara S; Hirakawa T; Amada S; Ariyoshi K; Nakano H
    J Obstet Gynaecol Res; 2004 Dec; 30(6):439-43. PubMed ID: 15566459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a 28-day oral contraceptive with 7 days of low-dose estrogen in place of placebo.
    Poindexter A; Reape KZ; Hait H
    Contraception; 2008 Aug; 78(2):113-9. PubMed ID: 18672111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proposed classification system for menstrual cycles in the menopause transition based on changes in serum hormone profiles.
    Robertson DM; Hale GE; Fraser IS; Hughes CL; Burger HG
    Menopause; 2008; 15(6):1139-44. PubMed ID: 18779761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial effects of a 91-day extended-regimen oral contraceptive with low-dose estrogen in place of placebo.
    Anderson FD; Feldman R; Reape KZ
    Contraception; 2008 Feb; 77(2):91-6. PubMed ID: 18226671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen.
    Klipping C; Duijkers I; Trummer D; Marr J
    Contraception; 2008 Jul; 78(1):16-25. PubMed ID: 18555813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
    Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
    Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal estradiol treatment suppresses serum gonadotropins during lactation without transfer into breast milk.
    Perheentupa A; Ruokonen A; Tapanainen JS
    Fertil Steril; 2004 Oct; 82(4):903-7. PubMed ID: 15482766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does hysterectomy affect ovarian function? Histopathologic evaluation and serum FSH, inhibin A, and inhibin B levels in an experimental rat model.
    Tapisiz OL; Gungor T; Aytan H; Zergeroglu S; Mulazimoglu B; Bilge U; Mollamahmutoglu L
    Eur J Obstet Gynecol Reprod Biol; 2008 Sep; 140(1):61-6. PubMed ID: 18499330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High serum concentration of total inhibin in polycystic ovary syndrome.
    Tsigkou A; Luisi S; De Leo V; Patton L; Gambineri A; Reis FM; Pasquali R; Petraglia F
    Fertil Steril; 2008 Nov; 90(5):1859-63. PubMed ID: 18423626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.